Ikarian Capital »

Avidity Biosciences Ord shares owned by Ikarian Capital

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $8.9M 300k 29.52
2024-12-31 $15M 500k 29.08

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Rtw Investments
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Geode Capital Management
Polar Capital Holdings
Bellevue Group
Casdin Capital
Goldman Sachs Group
OrbiMed Advisors

View all funds holding Avidity Biosciences Ord